| Current Price | $295.92 | Mkt Cap | $77.5B |
|---|---|---|---|
| Open | $300.05 | P/E Ratio | 51.02 |
| Prev. Close | $299.06 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $292.13 - $301.65 | Volume | 1,481,479 |
| 52-Wk Range | $165.23 - $306.08 | Avg. Daily Vol. | 1,932,661 |
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
| Current Price | $295.92 | Mkt Cap | $77.5B |
|---|---|---|---|
| Open | $300.05 | P/E Ratio | 51.02 |
| Prev. Close | $299.06 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $292.13 - $301.65 | Volume | 1,481,479 |
| 52-Wk Range | $165.23 - $306.08 | Avg. Daily Vol. | 1,932,661 |
The best Bull and Bear pitches based on recency and number of recommendations.
Vertex's earnings growth since 2016 as well as its development of non-opioid pain management drugs are reasons to be bullish.
Read the most recent pitches from players about VRTX.
Recs
nigelsjthomas
(89.78)
Submitted: 5/31/2020 5:20:23 PM :
Start Price:
$281.35
NASDAQ:VRTX Score:
+1.16
Great CEO
Recs
dmacdistance
(32.12)
Submitted: 5/28/2020 9:14:48 AM :
Start Price:
$276.27
NASDAQ:VRTX Score:
+3.34
Will have good growth with CF drugs gaining access to all and opening up new markets.
Recs
ajgreensa
(66.54)
Submitted: 5/11/2020 4:57:29 PM :
Start Price:
$271.45
NASDAQ:VRTX Score:
+1.56
Leader in CF gene editing with a robust platform for utilization in other disease indications. In addition the company is profitable and a collaboration with CRISPR therapeutics has upside potential.
Find the members with the highest scoring picks in VRTX.
bugeyebear (48.06) Score: +1,768.95
The Score Leader is the player with the highest score across all their picks in VRTX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| bugeyebear | 48.06 | 3/17/2008 |
|
3Y | $14.60 | +1,926.85% | +157.90% | +1,768.95 | 0 Comment | |
| lostontheprairie | 68.38 | 3/12/2008 |
|
5Y | $14.99 | +1,874.12% | +148.02% | +1,726.10 | 0 Comment | |
| Kudude | 83.17 | 3/12/2008 |
|
5Y | $14.99 | +1,874.12% | +148.02% | +1,726.10 | 0 Comment | |
| Salilp | 72.57 | 3/17/2008 |
|
5Y | $15.07 | +1,863.64% | +160.10% | +1,703.54 | 0 Comment | |
| davidmouw2 | < 20 | 3/14/2008 |
|
NS | $15.43 | +1,817.82% | +147.95% | +1,669.88 | 0 Comment | |
|
snazzysnazz | 69.22 | 3/13/2008 |
|
5Y | $15.49 | +1,810.39% | +154.01% | +1,656.39 | 0 Comment |
| NovaMechanika | 36.43 | 3/20/2008 |
|
3Y | $15.55 | +1,803.02% | +151.90% | +1,651.12 | 2 Comments | |
| stnewbie | 72.73 | 3/12/2008 |
|
NS | $15.78 | +1,775.29% | +149.15% | +1,626.14 | 0 Comment | |
| PrincetonAl | 86.20 | 3/7/2008 |
|
3Y | $15.86 | +1,765.83% | +153.97% | +1,611.86 | 1 Comment | |
|
|
hayrettin | 71.37 | 3/24/2008 |
|
5Y | $16.47 | +1,696.72% | +145.73% | +1,550.99 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
